440 related articles for article (PubMed ID: 31327827)
1. Aseptic Meningitis as an Initial Manifestation of Anti-myelin Oligodendrocyte Glycoprotein Antibody-associated Disease.
Suzuki T; Maekawa K; Matsuo K; Yamasaki M; Shibata M; Takahashi T; Naito Y
Intern Med; 2019 Nov; 58(22):3319-3321. PubMed ID: 31327827
[TBL] [Abstract][Full Text] [Related]
2. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
4. Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review.
Gombolay GY; Gadde JA
J Neuroimmunol; 2021 Sep; 358():577653. PubMed ID: 34229204
[TBL] [Abstract][Full Text] [Related]
5. Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare.
Shi B; Jiang W; He M; Sun H; Sun X; Yang Y; Yao J; Wu L; Huang D
Mult Scler Relat Disord; 2020 Jun; 41():102013. PubMed ID: 32088653
[TBL] [Abstract][Full Text] [Related]
6. Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report.
Zhang C; Zhang K; Chen B; Yin J; Dong M; Qin Y; Yang X
BMC Neurol; 2021 Mar; 21(1):109. PubMed ID: 33750325
[TBL] [Abstract][Full Text] [Related]
7. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
8. [A case of suspected neuromyelitis optica spectrum disorder preceded by aseptic meningitis-like symptoms].
Odachi K; Iio K; Uno K; Kawada N; Tomimoto H
Rinsho Shinkeigaku; 2019 Nov; 59(11):736-739. PubMed ID: 31656264
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
10. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
11. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
[No Abstract] [Full Text] [Related]
13. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
[TBL] [Abstract][Full Text] [Related]
14. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
Narayan R; Simpson A; Fritsche K; Salama S; Pardo S; Mealy M; Paul F; Levy M
Mult Scler Relat Disord; 2018 Oct; 25():66-72. PubMed ID: 30048919
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
16. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
Akaishi T; Sato DK; Takahashi T; Nakashima I
Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
[TBL] [Abstract][Full Text] [Related]
18. [Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic's disease: A case report].
Oji S; Yamaga T; Suzuki M; Tanaka S; Fukaura H; Nomura K
Rinsho Shinkeigaku; 2020 Mar; 60(3):219-222. PubMed ID: 32101847
[TBL] [Abstract][Full Text] [Related]
19. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
20. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
Kaushik M; Burdon MA
J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]